High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

BJU International

Volumn 101, Issue 10, 2008, Pages 1205-1213

  Rebillard, Xavier ^a   Soulié, Michel ^b   Chartier Kastler, Emmanuel ^c   Davin, Jean Louis ^d   Mignard, Jean Pierre ^e   Moreau, Jean Luc ^e   Coulange, Christian ^f  

^a Clinique Beau Soleil   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Clinique Rhone Durance   (France)

^e Conception Hospital ^*

^f APHM   (France)

Author keywords

High intensity focused ultrasound; Prostate cancer; Safety; Survival; Systematic literature review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLADDER NECK STENOSIS; CANCER CONTROL; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PRACTICE; DATA ANALYSIS; DEVICE; DISEASE FREE SURVIVAL; EMBASE; ERECTILE DYSFUNCTION; FOLLOW UP; GLEASON SCORE; HEALTH CARE ORGANIZATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MEDLINE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SALVAGE THERAPY; SHORT SURVEY; STATISTICAL ANALYSIS; STRESS INCONTINENCE; SURVIVAL RATE; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; TRANSURETHRAL RESECTION; TUMOR BIOPSY; URETHRA STENOSIS; URETHRA STRICTURE; URINARY TRACT INFECTION;

EID: 42249110861     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07504.x     Document Type: Short Survey

References (55)

1. Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2005 48 : 546 51
2. NICE. High-intensity focused ultrasound for prostate cancer. Available at: http://www.nice.org.uk/guidance/IPG118. Accessed July 2007
3. Azzouz H, de la Rosette JJMCH. HIFU: local treatment of prostate cancer. EAU-EBU Update Ser 2006 4 : 62 70
4. Acher PL, Hodgson DJ, Murphy DG, Cahill DJ. High-intensity focused ultrasound for treating prostate cancer. BJU Int 2006 99 : 28 32
5. Poissonnier L, Chapelon JY, Rouvière O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007 51 : 381 7
6. Blana A, Thüroff S, Murat FJ, Walter B, Chaussy C, Gelet A. Long-term results with high intensity focused ultrasound (HIFU) in 140 patients with localized prostate cancer. Eur Urol Suppl 2007 6 : 199, Abstract 708
7. Lee HM, Hong JH, Choi HY. High-intensity focused ultrasound therapy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis 2006 9 : 439 43
8. Mallick S, Dufour A, Fouques Y, Bensadoun H. High intensity focused ultrasound for the treatment of localized prostate cancer: are its efficacy and morbidity dogmatic? J Urol 2006 175 (Suppl. 4 365, Abstract 1134
9. Gelet A, Chapelon JY, Murat FJ et al. Prostate cancer control with transrectal HIFU in 124 patients: 7-years' actuarial results. Eur Urol Suppl 2006 5 : 133, Abstract 441
10. Zizzi V, Callea A, Piccinni R et al. High-intensity focused ultrasound (HIFU) in prostate cancer. Eur Urol Suppl 2006 5 : 133, Abstract 444
11. Chaussy C, Thueroff S, Knauer K. 10 years application of high intensity focused ultrasound (HIFU) in prostate cancer (PCA). Eur Urol Suppl 2006 5 : 133, Abstract 442
12. Gelet A, Chapelon JY, Poissonnier L et al. Prostate cancer control with transrectal HIFU in 230 patients: five-year results. J Urol 2005 173 (Suppl. 4 274, Abstract 1011
13. Poissonnier L, Gelet A, Chapelon JY et al. Prostate cancer control with transrectal HIFU in 230 patients: five-year results. Eur Urol Suppl 2005 4 : 44, Abstract 167
14. Thueroff S, Chaussy C. Efficacy of local high intensity focused ultrasound (HIFU) in localized prostate cancer. J Urol 2005 173 (Suppl. 4 279, Abstract 1028
15. Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004 63 : 297 300
16. Thüroff S, Chaussy C, Vallancien G et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003 17 : 673 7
17. Gelet A, Chapelon JY, Bouvier R, Rouvière O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001 40 : 124 9
18. Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001 15 : 437 40
19. Chaussy C, Thüroff S. High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol 2000 4 : 179 82
20. Gelet A, Chapelon JY, Bouvier R et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000 14 : 519 28
21. Chaussy CG, Thuroff S. High-intensive focused ultrasound in localized prostate cancer. J Endourol 2000 14 : 293 9
22. Beerlage HP, Thüroff S, Debruyne FM, Chaussy C, de la Rosette JJ. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 1999 54 : 273 7
23. Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 2006 97 : 56 61
24. Uchida T, Ohkusa H, Yamashita H et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006 13 : 228 33
25. Uchida T, Illing RO, Cathcart PJ, Emberton M. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy. BJU Int 2006 98 : 770 2
26. Uchida T, Illing RO, Cathcart PJ, Emberton M. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate? BJU Int 2006 98 : 537 9
27. Uchida T, Baba S, Irie A et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. Acta Urol Jpn 2005 51 : 651 8
28. Murat FJ, Poissonnier L, Rouvière O et al. High efficacy of salvage HIFU treatment for radio-recurrent prostate cancer in patient with good initial prognosis. Eur Urol Suppl 2007 6 : 200, Abstract 712
29. Murat FJ, Poissonnier L, Rouviere O et al. Salvage high intensity focused ultrasound (HIFU) treatment for recurrent prostate cancer after radiation therapy: high efficacy in patients with good initial prognosis. J Urol 2007 177 (Suppl. 591, Abstract 1777
30. Murat FJ, Poissonnier L, Gelet A. Recurrent prostate cancer after radiotherapy - salvage treatment by high intensity focused ultrasound. Eur Oncol Dis 2006 1 : 64 6
31. Murat FJ, Chapelon JY, Poissonnier L et al. Salvage HIFU for radiorecurrent prostate cancer: factors influencing the outcome. Eur Urol Suppl 2006 5 : 133, Abstract 443
32. Poissonnier L, Gelet A, Chapelon JY et al. Local recurrence of prostate cancer after external beam radiation: early experience of salvage therapy using high intensity focused ultrasound. Eur Urol Suppl 2005 4 : 79, Abstract 306
33. Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004 63 : 625 9
34. Mallick S, Dufour A, Fouques Y, Bensadoun H. Salvage therapy using high intensity focused ultrasound for local recurrence of prostate cancer after radiation therapy. Eur Urol Suppl 2006 5 : 132, Abstract 440
35. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol 2006 24 : 585 90
36. Chaussy C, Thüroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003 4 : 248 52
37. Thüroff S, Chaussy C. High-intensity focused ultrasound: complications and adverse events. Mol Urol 2000 4 : 183 7
38. Thüroff S, Knauer K, Chaussy C. 10 years high-intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effects. Eur Urol Suppl 2006 5 : 132, Abstract 439
39. Thüroff S, Knauer K, Chaussy C. 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effects. J Urol 2006 173 (Suppl. 4 364, Abstract 1133
40. Thüroff S, Kiel HJ, Knauer K, Buehrend H, Chaussy C. High intensity focused ultrasound (HIFU) in prostate cancer - side effects after 1000 treatments in 8 years. Eur Urol Suppl 2005 4 : 82, Abstract 317
41. Chaussy C, Thüroff S. Side effects of transrectal high intensity focused ultrasound (HIFU) in the local treatment of prostate cancer in 8 years. J Urol 2005 173 (Suppl. 4 452, Abstract 1668
42. Rebillard X, Gelet A, Davin JL et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 2005 19 : 693 701
43. Wondergem N, de la Rosette JJ. HIFU and cryoablation - non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound? Minim Invasive Ther Allied Technol 2007 16 : 22 30
44. Blana A, Murat FJ, Walter B et al. First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer. Eur Urol, doi:10.1016/j.eururo.2007.10.062
45. Chodak GW, Thisted RA, Gerber GS et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994 330 : 242 8
46. Johansson JE. Expectant management of early stage prostatic cancer: Swedish experience. J Urol 1994 152 : 1753 6
47. Adolfsson J, Tribukait B, Levitt S. The 20-year outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era. The prognostic value of tumour ploidy and comorbidity. Eur Urol 2007 52 : 1028 35
48. Potters L, Klein EA, Kattan MW et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004 71 : 29 33
49. Marberger M. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation. Curr Opin Urol 2007 17 : 194 9
50. Alivizatos G, Skolarikos A. Incontinence and erectile dysfunction following radical prostatectomy: a review. Scientificworldjournal 2005 5 : 747 58
51. Liu M, Pickles T, Berthelet E et al. Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol 2005 74 : 197 201
52. Ponholzer A, Brössner C, Struhal G, Marszalek M, Madersbacher S. Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria. World J Urol 2006 24 : 325 30
53. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002 41 : 427 33
54. Burnett AL, Aus G, Canby-Hagino ED et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007 178 : 597 601
55. Conort P, Rischmann P, Bensadoun H et al. Résultats à cinq ans du traitement du cancer prostatique (CP) localisé par ultrasons focalisé de haute intensité (HIFU). Abstract accepted for the 101st Congrès Français d'Urologie. 14-17 November 2007